{
    "id": 26681,
    "fullName": "MSH3 loss",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "MSH3 loss indicates loss of the MSH3 gene, mRNA, and protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 4437,
        "geneSymbol": "MSH3",
        "terms": [
            "MSH3",
            "DUP",
            "FAP4",
            "MRP1"
        ]
    },
    "variant": "loss",
    "createDate": "07/05/2017",
    "updateDate": "07/19/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11385,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, KU60648 combined with irradiation resulted in enhanced sensitivity compared to KU60648 alone in MSH3 deficient colon cancer cells in culture, demonstrating reduced colony formation (PMID: 28224663).",
            "molecularProfile": {
                "id": 27976,
                "profileName": "MSH3 loss"
            },
            "therapy": {
                "id": 5968,
                "therapyName": "KU60648 + Radiotherapy",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9237,
                    "pubMedId": 28224663,
                    "title": "Loss of MLH1 sensitizes colon cancer cells to DNA-PKcs inhibitor KU60648.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28224663"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11386,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a MLH1 and MSH3 deficient colon cancer cell line demonstrated sensitivity to treatment with KU60648 in culture, showing decreased cell viability and reduced colony formation (PMID: 28224663).",
            "molecularProfile": {
                "id": 27977,
                "profileName": "MLH1 loss MSH3 loss"
            },
            "therapy": {
                "id": 5967,
                "therapyName": "KU60648",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9237,
                    "pubMedId": 28224663,
                    "title": "Loss of MLH1 sensitizes colon cancer cells to DNA-PKcs inhibitor KU60648.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28224663"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27976,
            "profileName": "MSH3 loss",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27977,
            "profileName": "MLH1 loss MSH3 loss",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}